kras mutation and glutathion JCI Targeting KRAS Mutant Cancers with
Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell Uncovering new therapeutic targets for a common KRAS mutation behind cancer Overcoming resistance to drugs targeting KRASG12C mutation Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma Cell Death & Disease kras mutation and glutathion glynac Interplays of glucose metabolism in pancreatic ductal adenocarcinoma GlyNAC Supplementation Improves Glutathione Deficiency,
Pay in 4 interest-free payments of $7.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




